AzTrials
AzTrials

Substance-Related DisordersPhase 2NCT03264872

Peer MI for Substance-using Emerging Adults

A Phase 2 study testing Peer-Enhanced Motivational Interviewing in people with Substance-Related Disorders, run by University of Illinois at Urbana-Champaign at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The main purpose of this project is to test whether Peer-Enhanced Motivational Interviewing (PMI) results in superior alcohol and marijuana use outcomes for emerging adults (EAs, ages 18-29) and their peers. Read more about this study

Who is it for?
Ages 18 to 29 yearsHealthy volunteers can take part
Conditions the study is for
Substance-Related Disorders
What is being tested?
Peer-Enhanced Motivational Interviewing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteUnited States
Study dates
8 Mar 2017to 31 Oct 2021
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • For the Target Client
  • Score 5 or higher on the AUDIT-C measure and/or use alcohol or marijuana 13 days or more out of the past 90 days,
  • Have a friend that they are willing to refer to the study to be their 'peer' (support) and that peer agrees to participate,
  • Are able to complete baseline and follow-up assessments and have a valid email,
  • Are willing to be video recorded, and
  • Are fluent in English
Show all 11Show fewer
  • For the Peer
  • Have weekly contact with the participating Target Client who referred them,
  • Are will to attend all study procedures (i.e. baseline assessment, intervention, follow up),
  • Are willing to be video record,
  • Are fluent in English

Who cannot join

  • For the Target Client
  • Are current students in the lead Investigator's classes,
  • Are seeking residential treatment at the time of the screening call,
  • Are incarcerated or court-ordered to receive treatment at the time of the screening call,
  • Use drugs besides marijuana or alcohol over 45 of the past 90 days.
  • For the Peer
Show all 11Show fewer
  • Are current students in the lead Investigator's classes,
  • Are seeking residential treatment at the time of the screening call,
  • Are incarcerated or court-ordered to receive treatment at the time of the screening call,
  • Use drugs besides marijuana or alcohol over 45 of the past 90 days,
  • Are romantic partners of the Target Client

Trial locations and contacts

1 site in 1 country.

Douglas C Smith, PhD contact

217-333-5308

smithdc@illinois.edu

Catharaine Fairbairn, PhD contact

(217) 333-0631

cfairbai@illinois.edu

United States1 site, 1 recruiting
  • School of Social Work

    Urbana, Illinois, 61801

    Douglas C Smith, PhD, 217-333-5308, smithdc@illinois.edu

    Recruiting

Other trials in United States

About this study

Official title: Peer-enhanced Motivational Interviewing for Emerging Adults With Risky Substance Use

The main purpose of this project is to test whether Peer-Enhanced Motivational Interviewing (PMI) results in superior alcohol and marijuana use outcomes for emerging adults (EAs, ages 18-29) and their peers. Ninety peer dyads (total n = 180, ntarget client = 90, npeer = 90) are randomized to receive either Peer-Enhanced Motivational Interviewing (PMI) or Waitlist Control (WC).

Read the detailed description

This project randomized peer dyads, consisting of one EA (Emerging Adult; 18-29 years old) with a substance use problem (i.e. target client) and one peer, to one of two conditions. In the Peer-Enhanced Motivational Interviewing (PMI) condition, target clients and peers will receive separate one-hour sessions of Motivational Interviewing (MI) , an empirically-supported treatment that helps individuals work through ambivalence about making changes in substance use. MI is thought to work because it is a non-confrontational intervention where a therapist empathetically reviews substance use behaviors, listens empathetically, and reinforces any client statements indicating a desire to change. With the 'peer' of each PMI dyad, the therapist presents peers with data about the extent of the target client's substance use, builds the peer's motivation to help their friend, and teaches the peer communication skills they can use to influence the target client's substance use. In the WC condition, target clients and peers can receive PMI after the study follow-up period. Both target clients and their peers are followed for 12 weeks post-intervention.

The main purpose of this project is to test whether Peer-Enhanced Motivational Interviewing (PMI) results in superior alcohol and marijuana use outcomes for emerging adults (EAs, ages 18-29) and their peers. Ninety peer dyads (total n = 180, ntarget client = 90, npeer = 90) are randomized to receive either Peer-Enhanced Motivational Intervie (PMI) or Waitlist Control (WC).

Being tested
Peer-Enhanced Motivational Interviewing, Waitlist Control
Keywords
Motivational Interviewing
Medical subject headings
Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Peer-Enhanced Motivational InterviewingBehavioural

    Target clients in this Peer-Enhanced Motivational Interviewing arm will receive separate one-hour Motivational Interviewing (MI) sessions, in which the therapist reviews the target clients substance use behaviors in a non-confrontational manner, listens empathetically, and reinforces any client statements indicating a desire the change. In this arm, the therapist also presents the target client's peer with data about the extent of the target client's substance use, builds the peer's motivation to help their friend, and teaches the peer communication sills they can use to influence the target client's substance use behaviors.

  • Waitlist ControlOther

    After the 12 week follow up period, if subjects in the Waitlist Control group desire to receive the Peer-Enhanced Motivational Interviewing intervention, that will be made available to them.

Study groups in NCT03264872
Study groupRoleWhat they receive
Peer-Enhanced Motivational InterviewingExperimentalBoth dyad members, the target client and their peer support person, in this Peer-Enhanced Motivational Interviewing arm will receive separate one-hour Motivational Interviewing (MI) sessions with a trained counselor.
Receives: Behavioral: Peer-Enhanced Motivational Interviewing
Waitlist ControlOtherDelayed Treatment.
Receives: Other: Waitlist Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. GAIN Substance Problem Scale

    a 16-item scale composed of lifetime symptoms of substance abuse, dependence, and substance-induced health and psychological disorders based on the DSM-IV

    Measured: Baseline and every 2 weeks during 12 week post-intervention period

Secondary outcomes (3)
  1. GAIN Substance Frequency Scale (change)

    The GAIN substance frequency scale (SFS) measures the percent of days of substance use and percent of days of related problems from such substance use. This scale encompasses a large number of classes of substances, found to be ideal for measurement among poly- substance using individuals.

    Measured: Baseline and every 2 weeks during 12 week post-intervention period

  2. Rutgers Alcohol Problem Index (change)

    a 23-item self-administered screening tool (questionnaire) for assessing adolescent problem drinking. Respondents simply circle the number that corresponds to the number of times they have experienced each problem. Items can also be read aloud by an interviewer to clients with reading difficulties or it can be used as a springboard for a discussion of problems related to the client's alcohol use.

    Measured: Baseline and every 2 weeks during 12 week post-intervention period

  3. Significant Other Behavior Questionnaire

    An instrument measuring the specific social support in terms of the patient's drinking. Assessments of the significant other's behavior in the presence of the patient drinking is provided by both the patient and significant other.

    Measured: Baseline and every 2 weeks during 12 week post-intervention period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2017
  2. Study start8 Mar 2017
  3. Primary completion1 Oct 2021 (estimated)
  4. Study completion31 Oct 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03264872
Sponsor's protocol ID
IRB17393
Status last verified
Oct 2018
First submitted
23 Aug 2017
Last updated
12 Oct 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Peer-Enhanced Motivational Interviewing in people with Substance-Related Disorders, run by University of Illinois at Urbana-Champaign at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Douglas C Smith, PhD (217-333-5308, smithdc@illinois.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

GAIN Substance Problem Scale (time frame: Baseline and every 2 weeks during 12 week post-intervention period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Oct 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in